Tag: patent challenge
Jan, 24 2026
Paragraph IV Certifications: How Generic Drug Makers Legally Challenge Patents
Paragraph IV certifications let generic drug makers legally challenge brand-name patents before launch. This Hatch-Waxman Act mechanism saves billions in healthcare costs and drives generic competition in the U.S.